Autoantibodies in Multiple Sclerosis Patients Before and During IFN- <i>β</i> 1b Treatment: Are They Correlated with the Occurrence of Autoimmune Diseases?
E. Verdun(University of Turin), Luca Durelli(University of Turin), Angelo Ghezzi, E. Montanari(University of Milan), Bruno Ferrero(University of Turin), G. Isoardo(University of Turin), Alessandra Oggero(University of Turin), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Cited by 31
Related Papers
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Evidence of early cortical atrophy in MS
|Neurology|2003|485
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268